Jamie Christensen, SVP, Chief Science Officer at Mirati Therapeutics, Inc. (MRTX), sold 10,814 shares at $27.00 ($292K) on 2018-01-16, disclosed to the SEC on 2018-01-18.
Open-market sale of $292k MRTX by SVP, Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRTX | SELL | 2023-12-19 | $275K | — | Filing → |
| MRTX | SELL | 2023-09-12 | $170K | — | Filing → |
| MRTX | SELL | 2023-05-24 | $28K | — | Filing → |